Introduced about a century ago, suramin remains a frontline drug for the management of early-stage East African trypanosomiasis (sleeping sickness). Cellular entry into the causative agent, the protozoan parasite Trypanosoma brucei, occurs through receptor-mediated endocytosis involving the parasite's invariant surface glycoprotein 75 (ISG75), followed by transport into the cytosol via a lysosomal transporter. The molecular basis of the trypanocidal activity of suramin remains unclear, but some evidence suggests broad, but specific, impacts on trypanosome metabolism (i.e. polypharmacology). Here we observed that suramin is rapidly accumulated in trypanosome cells proportionally to ISG75 abundance. Although we found little evidence that suramin disrupts glycolytic or glycosomal pathways, we noted increased mitochondrial ATP production, but a net decrease in cellular ATP levels. Metabolomics highlighted additional impacts on mitochondrial metabolism, including partial Krebs' cycle activation and significant accumulation of pyruvate, corroborated by increased expression of mitochondrial enzymes and transporters. Significantly, the vast majority of suramin-induced proteins were normally more abundant in the insect forms compared with the blood stage of the parasite, including several proteins associated with differentiation. We conclude that suramin has multiple and complex effects on trypanosomes, but unexpectedly partially activates mitochondrial ATP-generating activity. We propose that despite apparent compensatory mechanisms in drug-challenged cells, the suramin-induced collapse of cellular ATP ultimately leads to trypanosome cell death.

Department of Biological and Medical Sciences Oxford Brookes University Oxford United Kingdom

Department of Pathology University of Cambridge Cambridge United Kingdom

Institute for Infection Immunity and Inflammation College of Medical Veterinary and Life Sciences University of Glasgow Glasgow United Kingdom

Institute of Parasitology Biology Centre Czech Academy of Sciences Institute of Parasitology Faculty of Science University of South Bohemia České Budějovice Czech Republic

School of Life Sciences University of Dundee Dundee Scotland United Kingdom

School of Life Sciences University of Nottingham Nottingham United Kingdom

Wellcome Centre for Integrative Parasitology and Glasgow Polyomics University of Glasgow Glasgow United Kingdom

Zobrazit více v PubMed

Barrett M. P., Vincent I. M., Burchmore R. J., Kazibwe A. J., and Matovu E. (2011) Drug resistance in human African trypanosomiasis. Future Microbiol. 6, 1037–1047 10.2217/fmb.11.88 PubMed DOI

Field M. C., Horn D., Fairlamb A. H., Ferguson M. A., Gray D. W., Read K. D., De Rycker M., Torrie L. S., Wyatt P. G., Wyllie S., and Gilbert I. H. (2017) Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need. Nat. Rev. Microbiol. 15, 217–231 10.1038/nrmicro.2016.193 PubMed DOI PMC

Fairlamb A. H., and Horn D. (2018) Melarsoprol resistance in African trypanosomiasis. Trends Parasitol. 34, 481–492 10.1016/j.pt.2018.04.002 PubMed DOI

Giordani F., Morrison L. J., Rowan T. G., de Koning H. P., Barrett M. P. (2016) The animal trypanosomiases and their chemotherapy: a review. Parasitology 143, 1862–1889 10.1017/S0031182016001268 PubMed DOI PMC

Chong J., Soufan O., Li C., Caraus I., Li S., Bourque G., Wishart D. S., Xia J. (2018) MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 46, W486–W494 10.1093/nar/gky310 PubMed DOI PMC

Mesu V. K. B. K., Kalonji W. M., Bardonneau C., Mordt O. V., Blesson S., Simon F., Delhomme S., Bernhard S., Kuziena W., Lubaki J. F., Vuvu S. L., Ngima P. N., Mbembo H. M., Ilunga M., Bonama A. K., et al. (2018) Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. Lancet 391, 144–154 10.1016/S0140-6736(17)32758-7 PubMed DOI

Akama T., Zhang Y. K., Freund Y. R., Berry P., Lee J., Easom E. E., Jacobs R. T., Plattner J. J., Witty M. J., Peter R., Rowan T. G., Gillingwater K., Brun R., Nare B., Mercer L., et al. (2018) Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT). Bioorg. Med. Chem. Lett. 28, 6–10 10.1016/j.bmcl.2017.11.028 PubMed DOI PMC

Zhang N., Zoltner M., Leung K. F., Scullion P., Hutchinson S., Del Pino R. C., Vincent I. M., Zhang Y. K., Freund Y. R., Alley M. R. K., Jacobs R. T., Read K. D., Barrett M. P., Horn D., and Field M. C. (2018) Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaboroles. PLoS Pathog. 14, e1006850 10.1371/journal.ppat.1006850 PubMed DOI PMC

Wall R. J., Rico E., Lukac I., Zuccotto F., Elg S., Gilbert I. H., Freund Y., Alley M. R. K., Field M. C., Wyllie S., and Horn D. (2018) Clinical and veterinary trypanocidal benzoxaboroles target CPSF3. Proc. Natl. Acad. Sci. U.S.A. 115, 9616–9621 10.1073/pnas.1807915115 PubMed DOI PMC

Begolo D., Vincent I. M., Giordani F., Pöhner I., Witty M. J., Rowan T. G., Bengaly Z., Gillingwater K., Freund Y., Wade R. C., Barrett M. P., and Clayton C. (2018) The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing. PLoS Pathog. 14, e1007315 10.1371/journal.ppat.1007315 PubMed DOI PMC

Sonoiki E., Ng C. L., Lee M. C., Guo D., Zhang Y. K., Zhou Y., Alley M. R., Ahyong V., Sanz L. M., Lafuente-Monasterio M. J., Dong C., Schupp P. G., Gut J., Legac J., Cooper R. A., et al. (2017) A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue. Nat. Commun. 8, 14574 10.1038/ncomms14574 PubMed DOI PMC

Alsford S., Eckert S., Baker N., Glover L., Sanchez-Flores A., Leung K. F., Turner D. J., Field M. C., Berriman M., and Horn D. (2012) High-throughput decoding of antitrypanosomal drug efficacy and resistance. Nature 482, 232–236 10.1038/nature10771 PubMed DOI PMC

Thomas J. A., Baker N., Hutchinson S., Dominicus C., Trenaman A., Glover L., Alsford S., and Horn D. (2018) Insights into antitrypanosomal drug mode-of-action from cytology-based profiling. PLoS Negl. Trop. Dis. 12, e0006980 10.1371/journal.pntd.0006980 PubMed DOI PMC

Scott A. G., Tait A., and Turner C. M. (1996) Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin. Acta Trop. 60, 251–262 10.1016/0001-706X(96)00131-3 PubMed DOI

Fang Y., Ye W. X., Nei H. Y., and Wang Y. L. (1994) In vitro development of suramin-resistant clones of Trypanosoma evansi. Acta Trop. 58, 79–83 10.1016/0001-706X(94)90123-6 PubMed DOI

Abebe G., Jones T. W., and Boid R. (1983) Suramin sensitivity of stocks of Trypanosoma evansi isolated in the Sudan. Trop. Anim. Health Prod. 15, 151–152 10.1007/BF02239924 PubMed DOI

Wiedemar N., Graf F. E., Zwyer M., Ndomba E., Kunz Renggli C., Cal M., Schmidt R. S., Wenzler T., and Mäser P. (2018) Beyond immune escape: a variant surface glycoprotein causes suramin resistance in Trypanosoma brucei. Mol. Microbiol. 107, 57–67 10.1111/mmi.13854 PubMed DOI

Wiedemar N., Zwyer M., Zoltner M., Cal M., Field M. C., and Mäser P. (2019) Expression of a specific variant surface glycoprotein has a major impact on suramin sensitivity and endocytosis in Trypanosoma brucei. FASEB Bioadv. 1, 595–608 10.1096/fba.2019-00033 PubMed DOI PMC

Vansterkenburg E. L., Coppens I., Wilting J., Bos O. J., Fischer M. J., Janssen L. H., and Opperdoes F. R. (1993) The uptake of the trypanocidal drug suramin in combination with low-density lipoproteins by Trypanosoma brucei and its possible mode of action. Acta Trop. 54, 237–250 10.1016/0001-706X(93)90096-T PubMed DOI

Pal A., Hall B. S., and Field M. C. (2002) Evidence for a non-LDL-mediated entry route for the trypanocidal drug suramin in Trypanosoma brucei. Mol. Biochem. Parasitol. 122, 217–221 10.1016/S0166-6851(02)00096-8 PubMed DOI

Zoltner M., Leung K. F., Alsford S., Horn D., and Field M. C. (2015) Modulation of the surface proteome through multiple ubiquitylation pathways in African trypanosomes. PLoS Pathog. 11, e1005236 10.1371/journal.ppat.1005236 PubMed DOI PMC

McCain D. F., Wu L., Nickel P., Kassack M. U., Kreimeyer A., Gagliardi A., Collins D. C., and Zhang Z. Y. (2004) Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases. J. Biol. Chem. 279, 14713–14725 10.1074/jbc.M312488200 PubMed DOI

St. Aubin C. N., Zhou J. J., and Linsdell P. (2007) Identification of a second blocker binding site at the cytoplasmic mouth of the cystic fibrosis transmembrane conductance regulator chloride channel pore. Mol. Pharmacol. 71, 1360–1368 10.1124/mol.106.031732 PubMed DOI

Wu K., Chong R. A., Yu Q., Bai J., Spratt D. E., Ching K., Lee C., Miao H., Tappin I., Hurwitz J., Zheng N., Shaw G. S., Sun Y., Felsenfeld D. P., Sanchez R., et al. (2016) Suramin inhibits cullin-RING E3 ubiquitin ligases. Proc. Natl. Acad. Sci. U.S.A. 113, E2011–E2018 10.1073/pnas.1601089113 PubMed DOI PMC

Stein C. A., LaRocca R. V., Thomas R., McAtee N., and Myers C. E. (1989) Suramin: an anticancer drug with a unique mechanism of action. J. Clin. Oncol. 7, 499–508 10.1200/JCO.1989.7.4.499 PubMed DOI

Albulescu I. C., Kovacikova K., Tas A., Snijder E. J., and van Hemert M. J. (2017) Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles. Antiviral Res. 143, 230–236 10.1016/j.antiviral.2017.04.016 PubMed DOI

Tan C. W., Sam I. C., Chong W. L., Lee V. S., and Chan Y. F. (2017) Polysulfonate suramin inhibits Zika virus infection. Antiviral Res. 143, 186–194 10.1016/j.antiviral.2017.04.017 PubMed DOI

Naviaux R. K., Curtis B., Li K., Naviaux J. C., Bright A. T., Reiner G. E., Westerfield M., Goh S., Alaynick W. A., Wang L., Capparelli E. V., Adams C., Sun J., Jain S., He F., et al. (2017) Low-dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial. Ann. Clin. Transl. Neurol. 4, 491–505 10.1002/acn3.424 PubMed DOI PMC

Schuetz A., Min J., Antoshenko T., Wang C. L., Allali-Hassani A., Dong A., Loppnau P., Vedadi M., Bochkarev A., Sternglanz R., and Plotnikov A. N. (2007) Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. Structure 15, 377–389 10.1016/j.str.2007.02.002 PubMed DOI

Michels P. A., Bringaud F., Herman M., and Hannaert V. (2006) Metabolic functions of glycosomes in trypanosomatids. Biochim. Biophys. Acta 1763, 1463–1477 10.1016/j.bbamcr.2006.08.019 PubMed DOI

Morgan H. P., McNae I. W., Nowicki M. W., Zhong W., Michels P. A., Auld D. S., Fothergill-Gilmore L. A., and Walkinshaw M. D. (2011) The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site. J. Biol. Chem. 286, 31232–31240 10.1074/jbc.M110.212613 PubMed DOI PMC

Willson M., Callens M., Kuntz D. A., Perié J., and Opperdoes F. R. (1993) Synthesis and activity of inhibitors highly specific for the glycolytic enzymes from Trypanosoma brucei. Mol. Biochem. Parasitol. 59, 201–210 10.1016/0166-6851(93)90218-M PubMed DOI

Rotureau B., Subota I., and Bastin P. (2011) Molecular bases of cytoskeleton plasticity during the Trypanosoma brucei parasite cycle. Cell Microbiol. 13, 705–716 10.1111/j.1462-5822.2010.01566.x PubMed DOI

Leung K. F., Riley F. S., Carrington M., and Field M. C. (2011) Ubiquitylation and developmental regulation of invariant surface protein expression in trypanosomes. Eukaryot. Cell 10, 916–931 10.1128/EC.05012-11 PubMed DOI PMC

Alsford S., Field M. C., and Horn D. (2013) Receptor-mediated endocytosis for drug delivery in African trypanosomes: fulfilling Paul Ehrlich's vision of chemotherapy. Trends Parasitol. 29, 207–212 10.1016/j.pt.2013.03.004 PubMed DOI

Zoltner M., Horn D., de Koning H. P., and Field M. C. (2016) Exploiting the Achilles' heel of membrane trafficking in trypanosomes. Curr. Opin. Microbiol. 34, 97–103 10.1016/j.mib.2016.08.005 PubMed DOI PMC

Natesan S. K., Peacock L., Leung K. F., Gibson W., and Field M. C. (2010) Evidence that low endocytic activity is not directly responsible for human serum resistance in the insect form of African trypanosomes. BMC Res. Notes 3, 63 10.1186/1756-0500-3-63 PubMed DOI PMC

Schnaufer A., Clark-Walker G. D., Steinberg A. G., and Stuart K. (2005) The F1-ATP synthase complex in bloodstream stage trypanosomes has an unusual and essential function. EMBO J. 24, 4029–4040 10.1038/sj.emboj.7600862 PubMed DOI PMC

Šubrtová K., Panicucci B., and Zíková A. (2015) ATPaseTb2, a unique membrane-bound FoF1-ATPase component, is essential in bloodstream and dyskinetoplastic trypanosomes. PLoS Pathog. 11, e1004660 10.1371/journal.ppat.1004660 PubMed DOI PMC

Kerkhoven E. J., Achcar F., Alibu V. P., Burchmore R. J., Gilbert I. H., Trybiło M., Driessen N. N., Gilbert D., Breitling R., Bakker B. M., and Barrett M. P. (2013) Handling uncertainty in dynamic models: the pentose phosphate pathway in Trypanosoma brucei. PLoS Comput. Biol. 9, e1003371 10.1371/journal.pcbi.1003371 PubMed DOI PMC

Wiemer E. A., Michels P. A., and Opperdoes F. R. (1995) The inhibition of pyruvate transport across the plasma membrane of the bloodstream form of Trypanosoma brucei and its metabolic implications. Biochem. J. 312, 479–484 10.1042/bj3120479 PubMed DOI PMC

Sanchez M. A. (2013) Molecular identification and characterization of an essential pyruvate transporter from Trypanosoma brucei. J. Biol. Chem. 288, 14428–14437 10.1074/jbc.M113.473157 PubMed DOI PMC

Vanderheyden N., Wong J., and Docampo R. (2000) A pyruvate-proton symport and an H+-ATPase regulate the intracellular pH of Trypanosoma brucei at different stages of its life cycle. Biochem. J. 346, 53–62 10.1042/bj3460053 PubMed DOI PMC

Halestrap A. P., and Meredith D. (2004) The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 447, 619–628 10.1007/s00424-003-1067-2 PubMed DOI

Lamour N., Rivière L., Coustou V., Coombs G. H., Barrett M. P., and Bringaud F. (2005) Proline metabolism in procyclic Trypanosoma brucei is down-regulated in the presence of glucose. J. Biol. Chem. 280, 11902–11910 10.1074/jbc.M414274200 PubMed DOI

Spitznagel D., Ebikeme C., Biran M., Nic a' Bháird N., Bringaud F., Henehan G. T., and Nolan D. P. (2009) Alanine aminotransferase of Trypanosoma brucei—a key role in proline metabolism in procyclic life forms. FEBS J. 276, 7187–7199 10.1111/j.1742-4658.2009.07432.x PubMed DOI

Bringaud F., and Baltz T. (1993) Differential regulation of two distinct families of glucose transporter genes in Trypanosoma brucei. Mol. Cell. Biol. 13, 1146–1154 10.1128/MCB.13.2.1146 PubMed DOI PMC

Deramchia K., Morand P., Biran M., Millerioux Y., Mazet M., Wargnies M., Franconi J. M., and Bringaud F. (2014) Contribution of pyruvate phosphate dikinase in the maintenance of the glycosomal ATP/ADP balance in the Trypanosoma brucei procyclic form. J. Biol. Chem. 289, 17365–17378 10.1074/jbc.M114.567230 PubMed DOI PMC

Haanstra J. R., González-Marcano E. B., Gualdrón-López M., Michels P. A. (2016) Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasites. Biochim. Biophys. Acta 1863, 1038–1048 10.1016/j.bbamcr.2015.09.015 PubMed DOI

Urbaniak M. D., Guther M. L., and Ferguson M. A. (2012) Comparative SILAC proteomic analysis of Trypanosoma brucei bloodstream and procyclic lifecycle stages. PLoS ONE 7, e36619 10.1371/journal.pone.0036619 PubMed DOI PMC

Kovářová J., Pountain A. W., Wildridge D., Weidt S., Bringaud F., Burchmore R. J. S., Achcar F., and Barrett M. P. (2018) Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana. PLoS Pathog. 14, e1006953 10.1371/journal.ppat.1006953 PubMed DOI PMC

Stoffel S. A., Alibu V. P., Hubert J., Ebikeme C., Portais J. C., Bringaud F., Schweingruber M. E., and Barrett M. P. (2011) Transketolase in Trypanosoma brucei. Mol. Biochem. Parasitol. 179, 1–7 10.1016/j.molbiopara.2011.04.006 PubMed DOI

Mantilla B. S., Marchese L., Casas-Sánchez A., Dyer N. A., Ejeh N., Biran M., Bringaud F., Lehane M. J., Acosta-Serrano A., and Silber A. M. (2017) Proline metabolism is essential for Trypanosoma brucei brucei survival in the tsetse vector. PLoS Pathog. 13, e1006158 10.1371/journal.ppat.1006158 PubMed DOI PMC

Ong H. B., Lee W. S., Patterson S., Wyllie S., and Fairlamb A. H. (2015) Homoserine and quorum-sensing acyl homoserine lactones as alternative sources of threonine: a potential role for homoserine kinase in insect-stage Trypanosoma brucei. Mol. Microbiol. 95, 143–156 10.1111/mmi.12853 PubMed DOI PMC

Mazet M., Morand P., Biran M., Bouyssou G., Courtois P., Daulouède S., Millerioux Y., Franconi J. M., Vincendeau P., Moreau P., and Bringaud F. (2013) Revisiting the central metabolism of the bloodstream forms of Trypanosoma brucei: production of acetate in the mitochondrion is essential for parasite viability. PLoS Negl. Trop. Dis. 7, e2587 10.1371/journal.pntd.0002587 PubMed DOI PMC

Cross G. A. M., Klein R. A., and Linstead D. J. (1975) Utilization of amino acids by Trypanosoma brucei in culture: l-threonine as a precursor for acetate. Parasitology 71, 311–326 10.1017/S0031182000046758 PubMed DOI

Rivière L., van Weelden S. W., Glass P., Vegh P., Coustou V., Biran M., van Hellemond J. J., Bringaud F., Tielens A. G., and Boshart M. (2004) Acetyl:succinate CoA-transferase in procyclic Trypanosoma brucei: gene identification and role in carbohydrate metabolism. J. Biol. Chem. 279, 45337–45346 10.1074/jbc.M407513200 PubMed DOI

Rivière L., Moreau P., Allmann S., Hahn M., Biran M., Plazolles N., Franconi J. M., Boshart M., and Bringaud F. (2009) Acetate produced in the mitochondrion is the essential precursor for lipid biosynthesis in procyclic trypanosomes. Proc. Natl. Acad. Sci. U.S.A. 106, 12694–12699 10.1073/pnas.0903355106 PubMed DOI PMC

Štáfková J, Mach J., Biran M., Verner Z., Bringaud F., and Tachezy J. (2016) Mitochondrial pyruvate carrier in Trypanosoma brucei. Mol Microbiol. 100, 442–456 10.1111/mmi.13325 PubMed DOI

Colasante C., Peña Diaz P., Clayton C., and Voncken F. (2009) Mitochondrial carrier family inventory of Trypanosoma brucei brucei: identification, expression and subcellular localisation. Mol. Biochem. Parasitol. 167, 104–117 10.1016/j.molbiopara.2009.05.004 PubMed DOI

Veitch N. J., Johnson P. C., Trivedi U., Terry S., Wildridge D., and MacLeod A. (2010) Digital gene expression analysis of two life cycle stages of the human-infective parasite, Trypanosoma brucei gambiense reveals differentially expressed clusters of co-regulated genes. BMC Genomics 11, 124 10.1186/1471-2164-11-124 PubMed DOI PMC

Colasante C., Zheng F., Kemp C., and Voncken F. (2018) A plant-like mitochondrial carrier family protein facilitates mitochondrial transport of di- and tricarboxylates in Trypanosoma brucei. Mol. Biochem. Parasitol. 221, 36–51 10.1016/j.molbiopara.2018.03.003 PubMed DOI

Szöor B., Ruberto I., Burchmore R., and Matthews K. R. (2010) A novel phosphatase cascade regulates differentiation in Trypanosoma brucei via a glycosomal signaling pathway. Genes Dev. 24, 1306–1316 10.1101/gad.570310 PubMed DOI PMC

Silvester E., McWilliam K. R., and Matthews K. R. (2017) The cytological events and molecular control of life cycle development of Trypanosoma brucei in the mammalian bloodstream. Pathogens 6, E29 10.3390/pathogens6030029 PubMed DOI PMC

Dejung M., Subota I., Bucerius F., Dindar G., Freiwald A., Engstler M., Boshart M., Butter F., and Janzen C. J. (2016) Quantitative proteomics uncovers novel factors involved in developmental differentiation of Trypanosoma brucei. PLoS Pathog. 12, e1005439 10.1371/journal.ppat.1005439 PubMed DOI PMC

Chaudhuri M., Ott R. D., and Hill G. C. (2006) Trypanosome alternative oxidase: from molecule to function. Trends Parasitol. 22, 484–491 10.1016/j.pt.2006.08.007 PubMed DOI

Collins J. M., Klecker R. W. Jr, Yarchoan R., Lane H. C., Fauci A. S., Redfield R. R., Broder S., and Myers C. E. (1986) Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection. J. Clin. Pharmacol. 26, 22–26 10.1002/j.1552-4604.1986.tb02897.x PubMed DOI

Croci R., Pezzullo M., Tarantino D., Milani M., Tsay S. C., Sureshbabu R., Tsai Y. J., Mastrangelo E., Rohayem J., Bolognesi M., and Hwu J. R. (2014) Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds. PLoS ONE 9, e91765 10.1371/journal.pone.0091765 PubMed DOI PMC

Salvador G. H., Dreyer T. R., Cavalcante W. L., Matioli F. F., Dos Santos J. I., Velazquez-Campoy A., Gallacci M., and Fontes M. R. (2015) Structural and functional evidence for membrane docking and disruption sites on phospholipase A2-like proteins revealed by complexation with the inhibitor suramin. Acta Crystallogr. D Biol. Crystallogr. 71, 2066–2078 10.1107/S1399004715014443 PubMed DOI

Opoku-Temeng C., and Sintim H. O. (2016) Potent inhibition of cyclic diadenylate monophosphate cyclase by the antiparasitic drug, suramin. Chem. Commun. 52, 3754–3757 10.1039/C5CC10446G PubMed DOI

Zíková A., Verner Z., Nenarokova A., Michels P. A. M., and Lukeš J. (2017) A paradigm shift: the mitoproteomes of procyclic and bloodstream Trypanosoma brucei are comparably complex. PLoS Pathog. 13, e1006679 10.1371/journal.ppat.1006679 PubMed DOI PMC

Vickerman K. (1989) Trypanosome sociology and antigen variation. Parasitology 99, S37–S47 10.1017/S0031182000083402 PubMed DOI

Seed J. R., and Wenck M. A. (2003) Role of the long slender to short stumpy transition in the life cycle of the African trypanosomes. Kinetoplastid Biol. Dis. 2, 3 10.1186/1475-9292-2-3 PubMed DOI PMC

Mony B. M., MacGregor P., Ivens A., Rojas F., Cowton A., Young J., Horn D., and Matthews K. (2014) Genome-wide dissection of the quorum sensing signalling pathway in Trypanosoma brucei. Nature 505, 681–685 10.1038/nature12864 PubMed DOI PMC

Mony B. M., and Matthews K. R. (2015) Assembling the components of the quorum sensing pathway in African trypanosomes. Mol. Microbiol. 96, 220–232 10.1111/mmi.12949 PubMed DOI PMC

Saldivia M., Ceballos-Pérez G., Bart J. M., and Navarro M. (2016) The AMPKα1 pathway positively regulates the developmental transition from proliferation to quiescence in Trypanosoma brucei. Cell Rep. 17, 660–670 10.1016/j.celrep.2016.09.041 PubMed DOI PMC

Rico E., Rojas F., Mony B. M., Szoor B., MacGregor P., and Matthews K. R. (2013) Bloodstream form pre-adaptation to the tsetse fly in Trypanosoma brucei. Front. Cell. Infect. Microbiol. 3, 78 10.3389/fcimb.2013.00078 PubMed DOI PMC

Wenzler T., Schumann Burkard G., Schmidt R. S., Mäser P., Bergner A., Roditi I., and Brun R. (2016) A new approach to chemotherapy: drug-induced differentiation kills African trypanosomes. Sci Rep. 6, 22451 10.1038/srep22451 PubMed DOI PMC

Hirumi H., and Hirumi K. (1994) Axenic culture of African trypanosome bloodstream forms. Parasitol. Today 10, 80–84 10.1016/0169-4758(94)90402-2 PubMed DOI

Alsford S., and Horn D. (2008) Single-locus targeting constructs for reliable regulated RNAi and trans-gene expression in Trypanosoma brucei. Mol. Biochem. Parasitol. 161, 76–79 10.1016/j.molbiopara.2008.05.006 PubMed DOI PMC

Alsford S., Kawahara T., Glover L., and Horn D. (2005) Tagging a T. brucei RRNA locus improves stable transfection efficiency and circumvents inducible expression position effects. Mol. Biochem. Parasitol. 144, 142–148 10.1016/j.molbiopara.2005.08.009 PubMed DOI PMC

Redmond S., Vadivelu J., and Field M. C. (2003) RNAit: an automated web-based tool for the selection of RNAi targets in Trypanosoma brucei. Mol. Biochem. Parasitol. 128, 115–118 10.1016/S0166-6851(03)00045-8 PubMed DOI

Gadelha C., Rothery S., Morphew M., McIntosh J. R., Severs N. J., and Gull K. (2009) Membrane domains and flagellar pocket boundaries are influenced by the cytoskeleton in African trypanosomes. Proc. Natl. Acad. Sci. U.S.A. 106, 17425–17430 10.1073/pnas.0909289106 PubMed DOI PMC

Kremer J. R., Mastronarde D. N., and McIntosh J. R. (1996) Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116, 71–76 10.1006/jsbi.1996.0013 PubMed DOI

Koeller C. M., and Bangs J. D. (2019) Processing and targeting of cathepsin L (TbCatL) to the lysosome in Trypanosoma brucei. Cell Microbiol. 21, e12980 10.1111/cmi.12980 PubMed DOI

Lingnau A., Zufferey R., Lingnau M., and Russell D. G. (1999) Characterization of tGLP-1, a Golgi and lysosome-associated, transmembrane glycoprotein of African trypanosomes. J. Cell Sci. 112, 3061–3070 PubMed

Chung W. L., Leung K. F., Carrington M., and Field M. C. (2008) Ubiquitylation is required for degradation of transmembrane surface proteins in trypanosomes. Traffic 9, 1681–1697 10.1111/j.1600-0854.2008.00785.x PubMed DOI

Wallace L. J., Candlish D., and De Koning H. P. (2002) Different substrate recognition motifs of human and trypanosome nucleobase transporters. Selective uptake of purine antimetabolites. J. Biol. Chem. 277, 26149–26156 10.1074/jbc.M202835200 PubMed DOI

Cox J., and Mann M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 10.1038/nbt.1511 PubMed DOI

Aslett M., Aurrecoechea C., Berriman M., Brestelli J., Brunk B. P., Carrington M., Depledge D. P., Fischer S., Gajria B., Gao X., Gardner M. J., Gingle A., Grant G., Harb O. S., Heiges M., et al. (2010) TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res. 38, D457–D462 10.1093/nar/gkp851 PubMed DOI PMC

Tyanova S., Temu T., Sinitcyn P., Carlson A., Hein M. Y., Geiger T., Mann M., and Cox J. (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 10.1038/nmeth.3901 PubMed DOI

Perez-Riverol Y., Csordas A., Bai J., Bernal-Llinares M., Hewapathirana S., Kundu D. J., Inuganti A., Griss J., Mayer G., Eisenacher M., Pérez E., Uszkoreit J., Pfeuffer J., Sachsenberg T., Yilmaz S., et al. (2019) The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442–D450 10.1093/nar/gky1106 PubMed DOI PMC

Rattigan K. M., Pountain A. W., Regnault C., Achcar F., Vincent I. M., Goodyear C. S., Barrett M. P. (2018) Metabolomic profiling of macrophages determines the discrete metabolomic signature and metabolomic interactome triggered by polarising immune stimuli. PLoS ONE 13, e0194126 10.1371/journal.pone.0194126 PubMed DOI PMC

Chambers M. C., Maclean B., Burke R., Amodei D., Ruderman D. L., Neumann S., Gatto L., Fischer B., Pratt B., Egertson J., Hoff K., Kessner D., Tasman N., Shulman N., Frewen B., et al. (2012) A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 30, 918–920 10.1038/nbt.2377 PubMed DOI PMC

Gloaguen Y., Morton F., Daly R., Gurden R., Rogers S., Wandy J., Wilson D., Barrett M., and Burgess K. (2017) PiMP my metabolome: an integrated, web-based tool for LC-MS metabolomics data. Bioinformatics 33, 4007–4009 10.1093/bioinformatics/btx499 PubMed DOI PMC

Chokkathukalam A., Jankevics A., Creek D. J., Achcar F., Barrett M. P., and Breitling R. (2013) mzMatch-ISO: an R tool for the annotation and relative quantification of isotope-labelled mass spectrometry data. Bioinformatics 29, 281–283 10.1093/bioinformatics/bts674 PubMed DOI PMC

Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity

Functional differentiation of Sec13 paralogues in the euglenozoan protists

The role of invariant surface glycoprotein 75 in xenobiotic acquisition by African trypanosomes

The History of Anti-Trypanosome Vaccine Development Shows That Highly Immunogenic and Exposed Pathogen-Derived Antigens Are Not Necessarily Good Target Candidates: Enolase and ISG75 as Examples

Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei